Asthma and Respiratory Disorders News

Asthma increased the need for respiratory support in COVID-19 patients, whereas metabolic syndrome raised the risk for severe COVID-19, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Adults with asthma and/or COPD who received 23 text messages about preventer inhaler use over 26 weeks had improved inhaler adherence, according to a poster presented at the European Respiratory Society International Congress.

Patients with asthma on dupilumab saw reduced airway inflammation and mucus plugging beginning at 4 weeks with steady improvements through 24 weeks, according to a study presented at the European Respiratory Society International Congress.

Patients with asthma who used a glucagon-like peptide 1 receptor agonist for weight loss experienced improved asthma control, according to a poster presented at the European Respiratory Society International Congress.

Patients with severe eosinophilic asthma who used depemokimab administered every 6 months experienced a 54% reduction in exacerbations over 52 weeks, according to a study presented at the European Respiratory Society International Congress.

Patients with greater impairment before initiating biologic treatment for asthma had better response across all assessed outcomes, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Even patients with mild asthma sometimes experience acute exacerbations that require visits to the ED or hospitalization, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Adults aged 28 years faced heightened odds for respiratory symptoms if they began smoking before turning 18 years old, according to a presentation at the European Respiratory Society International Congress.

Air pollution increased the risk for ED visits and hospitalizations due to asthma and other respiratory diseases, according to a poster presented at ERS Congress 2024.

Air pollution and genetic susceptibility increased the risks for progression from asthma to COPD, according to a study presented at the European Respiratory Society International Congress.